课题基金 / 基金详情

The development of inhibitors for the infection using phage library

The development of inhibitors for the infection using phage library
利用噬菌体库开发感染抑制剂
批准号:
14380411
负责人:
SATO Toshinori
金额:
$5.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

SATO Toshinori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Influenza HA is known to bind sialylgalactoside having α2-3- or α2-6- linkages on host cells at the first step of infection. We attempted to design peptides as a universal inhibitor that bind to the receptor-binding pocket of HA.In order to obtain peptides which are a mimic of sialyl oligosaccharide, a phage-displayed random pentadecapeptide library have been employed. phage-displayed method is a selection technology using a pool of phage. It was expected that HA-binding peptides selected from the phage library would serve as inhibitors of influenza A virus. In this study, the HA-binding peptides and glycolipid-binding peptides were selected from the phage-displayed peptide libraries, and they inhibited the infection of both HA1 and HA3 subtypes of influenza virus to MDCK cells. Although the theoretical molecular diversity of pentadecapeptide is calculated to be 3.3x10^<19>, the phage library employed has only 2.5x10^8 kinds of diversity. Therefore, in order to obtain improved the HA-binding peptides, sublibrary generated from a selected sequence was prepared. The directed evolution approach was employed to prepare the sublibraries.The two kinds of sublibraries were constructed to obtain HA1- and HA3-binding peptides. Through the affinity selections for HA1 and HA3 using the sublibraries, several peptide sequences having mutations were obtained. Many of the mutant phage clones showed higher binding affinity for both HA1 and HA3 subtypes than the original A-1 phage. The evoluted peptides inhibited the infection of influenza virus to MDCK cells more efficiently than the original A-1 peptide.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间: 2002
期刊: Peptide Science 2001
影响因子: --
作者: [T.Sato, M.Sumi, K.Ogino, T.Taki]
通讯作者: T.Taki
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: []
通讯作者:
T.Sato et al.: "Inhibition of Influenza Virus Infection by Hemagglutinin-Binding Peputides"Peptide Science 2001. 329-330 (2002)
T.Sato 等人:“血凝素结合肽对流感病毒感染的抑制”肽科学 2001. 329-330 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Study on the Boso slow slip events through observation using ocean bottom pressure gauges and model simulation
  • 批准号:
    25287109
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.73万
  • 财政年份:
    2013
  • 负责人:
    SATO Toshinori
  • 依托单位:
Development of novel drug delivery system using ganglioside-binding peptides
  • 批准号:
    24650283
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2012
  • 负责人:
    SATO Toshinori
  • 依托单位:
A Study on Reconstructing Memory Hierarchy that Utilizes Emerging Devices
  • 批准号:
    23650026
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.25万
  • 财政年份:
    2011
  • 负责人:
    SATO Toshinori
  • 依托单位:
Comparative glycomics toward the analysis of molecular mechanism of tumor metastasis using saccharide primer method.
  • 批准号:
    22651083
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $1.83万
  • 财政年份:
    2010
  • 负责人:
    SATO Toshinori
  • 依托单位:
国内基金
海外基金
Peptide YY调控Hippo/YAP通路促进皮肤组织创面愈合的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    王晓
  • 依托单位:
靶向促黏多肽R-Peptide对iPSCs来源肝脏类器官培养体系的优化及机制研究
  • 批准号:
    32160230
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    36.00万元
  • 批准年份:
    2021
  • 负责人:
    姚佳
  • 依托单位:
降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
  • 批准号:
    81873385
  • 项目类别:
    面上项目
  • 资助金额:
    59.0万元
  • 批准年份:
    2018
  • 负责人:
    乔海法
  • 依托单位:
Peptide-PAMAM-galardin系统的构建及其诱导I型胶原仿生再矿化的分子机制研究
  • 批准号:
    81800965
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2018
  • 负责人:
    梁坤能
  • 依托单位: